Health Buzz: Johnson & Johnson Recalls Heartburn Drugs

Johnson & Johnson /McNeill Consumer Healthcare is a prime example of corporate corruption, dishonesty and malfeasance. What may be even worse is the fact that the main media outlets are not reporting the WHOLE story.

A TIMELINE OF THE MCNEIL CONSUMER HEALTHCARE / JOHNSON & JOHNSON RECALLS:

2008: The “phantom recall” took place, in which Johnson & Johnson allegedly hired contractors to pose as customers and buy adult Motrin in order to remove the product from store shelves.

November 2009: McNeil recalled five lots of Tylenol Arthritis Pain Caplet 100 count bottles because of an unusual smell or taste. Consumers reported nausea and related symptoms.

December 2009: McNeil expanded the November recall to include all lots of Tylenol Arthritis Pain 100 count.

January 15, 2010: Johnson & Johnson issued a massive recall of over-the-counter drugs because of a moldy smell-caused by the presence of a chemical called 2,4,6-tribromoanisole (TBA)- that made people sick. .

The FDA said about 70 people were sickened by the odor including nausea, stomach pain, vomiting and diarrhea.

March 31, 2010 – McNeil recalls Zyrtec Itchy Eye Drops

April 30, 2010: more than 40 types of children’s and infants’ products were voluntarily recalled. Quality issues included the medication containing too much of the active ingredient,substandard inactive ingredients, and tiny particles. The recall included more than 135 million bottles of children’s medication.

May 6, 2010 - Philadelphia Public Health Examiner: The FDA has charged that McNeil knew the raw material had known contamination with gram negative organisms [bacteria] yet approved it for use to manufacture several lots of Children's and Infant's Tylenol drug products.. . .

May 28, 2010: Blacksmith Brands, after conferring with the FDA, initiated a voluntary recall of four PediaCare children’s cough and cold products manufactured at the same plant.

June 15, 2010: McNeil expanded its Jan. 15, 2010, recall to include five more lots of Benadryl and Tylenol that were “inadvertently omitted from the initial recall action.” Congress announced it would investigate.

July 8, 2010: McNeil Consumer Healthcare recalled 21 more lots of over-the-counter medicines sold in the U.S., Fiji, Guatemala, Dominican Republic, Puerto Rico, Trinidad & Tobago and Jamaica.

Also, five complaints filed in the U.S. District Court for Northern Illinois against McNeil are seeking class-action status. Consumers accused McNeil of fraud and racketeering for not recalling all of its children’s products and for not adequately reimbursing consumers for their out-of-pocket expenses.

July 16, 2010 – Jere Beasley Report: Rep. Towns, chairman of the House Committee on Oversight and Government Reform, says Johnson & Johnson has used delaying tactics in its dealings with the committee and in some instances had provided misinformation. . . The FDA has referred the McNeil case to its office of criminal investigation.

Report the Truth of IL 1:30AM December 03, 2010